Opium, Urine
Familial Adenomatous Polyposis (APC) Gene Mutation Analysis
Bacterial Vaginosis Pathogens by Molecular Method
Phosphorylated tau 217 (pTau 217), Plasma, (Quest AD-Detect®, ALZpath pTau217)
Metanephrines, Fractionated, Random, Urine
Lymphocyte proliferation panel, Blood
Inducible Costimulator (ICOS) Gene mutation analysis
Nucleophosmin (NPM1) Gene Mutation Analysis
Peripheral Blood Smear Review (Manual Differential)
Rickettsia rickettsii (Rocky Mountain Spotted Fever) Antibodies, IgG & IgM by IFA
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
ICD10
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now